Aminopyridines Correct Early Dysfunction and Delay Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1

Journal of Neuroscience - United States
doi 10.1523/jneurosci.0905-11.2011
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Society for Neuroscience

Related search

PET and MRI Reveal Early Evidence of Neurodegeneration in Spinocerebellar Ataxia Type 17

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Molecular Pathogenesis and Cellular Pathology of Spinocerebellar Ataxia Type 7 Neurodegeneration

Cerebellum
MedicineNeurology
2008English

Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2007English

Non-Invasive Detection of Neurochemical Changes Prior to Overt Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2013English

Dendritic Potassium Channel Dysfunction May Contribute to Dendrite Degeneration in Spinocerebellar Ataxia Type 1

PLoS ONE
Multidisciplinary
2018English

Role of Tank-Binding Kinase in Neurodegeneration Produced by Spinocerebellar Ataxia Type 13

Biophysical Journal
Biophysics
2017English

Spinocerebellar Ataxia With Axonal Neuropathy Type 1

2020English

Rod-Cone Dystrophy in Spinocerebellar Ataxia Type 1

Archives of Ophthalmology
2011English

Gene Therapies for Spinocerebellar Ataxia Type 1

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy